Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Biotech  -  Page 4
Latest

Five tech business trends to watch in 2021

By   /  Thursday, December 31st, 2020  /  Biotech, Central Coast, East Ventura County, Latest news, middle, South Coast, Subscriber content, Technology, Top Stories, Tri-County Economy, West Ventura County  /  Comments Off on Five tech business trends to watch in 2021

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

‘Golden age of biotechnology’ comes to Conejo Valley

By   /  Friday, December 18th, 2020  /  Banking & Finance, Biotech, East Ventura County, Latest news, Startups, Subscriber content, Technology, Top Stories, Tri-County Economy  /  Comments Off on ‘Golden age of biotechnology’ comes to Conejo Valley

Westlake Village BioPartners has launched two new funds worth a total of $500 million, bringing the total raised by the firm to more than $820 million since it was founded in 2018.

Read More →
Latest

Westlake Village BioPartners puts $500 million into new venture funds

By   /  Tuesday, December 15th, 2020  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news, Small Business, Startups, Technology, Top Stories, Tri-County Economy  /  Comments Off on Westlake Village BioPartners puts $500 million into new venture funds

Westlake Village BioPartners, a venture capital firm focused on biotech startups in the Conejo Valley and the rest of greater Los Angeles, launched two new funds Dec. 15 worth a total of $500 million. The first fund is $70 million and will be used for Series B or later financing into companies that Westlake Village Read More →

Read More →
Latest

MannKind makes $12.5M pharma buy

By   /  Monday, December 7th, 2020  /  Banking & Finance, Biotech, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on MannKind makes $12.5M pharma buy

MannKind Corp., a biotech company based in Westlake Village, announced Dec. 7 that it has acquired a QrumPharma, a privately held biotech company, in a $12.5 million deal. MannKind has purchased all outstanding capital stock of QrumPharma for $3.5 million in cash and just over 3 million shares of MannKind common stock. At MannKind’s stock Read More →

Read More →
Latest

Amgen joins new cooperative trials for COVID treatment

By   /  Tuesday, December 1st, 2020  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen joins new cooperative trials for COVID treatment

With COVID-19 continuing to surge across the globe, a coalition of pharmaceutical companies including Thousand Oaks-based Amgen has announced a joint trial for new coronavirus treatments. Amgen, along with Takeda and UCB, are now collaborating to study methods of treatment for patients who are hospitalized due to COVID-19, the three companies announced. The trial enrolled Read More →

Read More →
Latest

Amgen beats expectations in Q3 earnings report

By   /  Wednesday, October 28th, 2020  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen beats expectations in Q3 earnings report

Amgen, one of the biggest biopharmaceutical companies in the world, continued to see growth in the third quarter of 2020, despite the COVID-19 pandemic. The Thousand Oaks-based company saw total revenue of $6.4 billion for the quarter, up 12 percent from the third quarter of 2019. Earnings per share increased 5 percent to $3.43. Both Read More →

Read More →
Latest

Arcutis shares up on news of public, private offerings

By   /  Tuesday, September 29th, 2020  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Arcutis shares up on news of public, private offerings

Arcutis Biotherapeutics saw a 15 percent rise in its share price after it said Sept. 29 that it will offer 4 million shares to the public and sell another $35 million in stock to an affiliate of one of its directors. Arcutis closed at $31.04, a gain of $4.28 after it announced the dual track Read More →

Read More →